D. Sosnowska

Perivascular macrophages collaborate to facilitate chemotherapy resistance in cancer

F. Watt, T. Lawrence, C. Gillett, 2022, bioRxiv.

Redox‐Triggered Nanomedicine via Lymphatic Delivery: Inhibition of Melanoma Growth by Ferroptosis Enhancement and a Pt(IV)‐Prodrug Chemoimmunotherapy Approach

J. Llop, A. Zabaleta, J. N. Arnold, 2022, Advanced Therapeutics.

Cytotoxic Chemotherapy as an Immune Stimulus: A Molecular Perspective on Turning Up the Immunological Heat on Cancer

J. Spicer, J. N. Arnold, James W. Opzoomer, 2019, Front. Immunol..

Macrophages orchestrate the expansion of a proangiogenic perivascular niche during cancer progression

S. Pinder, T. Lawrence, T. Ng, 2021, Science advances.

Osimertinib and anti-HER3 combination therapy engages immune dependent tumor toxicity via STING activation in trans

S. Iacobelli, J. Vicencio, S. Ameer-Beg, 2022, Cell Death & Disease.

Requirement of FAT and DCHS protocadherins during hypothalamic-pituitary development

F. Faucz, C. Stratakis, N. Pankratz, 2020, JCI insight.

LYVE-1+ macrophages form a collaborative CCR5-dependent perivascular niche that influences chemotherapy responses in murine breast cancer.

F. Watt, T. Lawrence, J. Burchell, 2023, Developmental cell.